Dazucorilant in Patients With Amyotrophic Lateral Sclerosis

Clinical trial NCT05407324 · RECRUITING

Trial details

NCT number: NCT05407324
Sponsor: Corcept Therapeutics
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-11-15
Primary completion: 2026-10-01
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.